Tumor immunotherapy with alternative reading frame peptide antigens

Immunobiology

Volumn 209, Issue 7, 2004, Pages 535-544

  Vidovic, Damir ^a,b  

^a Dendreon   (United States)

^b Medical Center General Hospital   (Croatia)

Author keywords

Alternative reading frames; Immunotherapy

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; CANCER VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; POLYPEPTIDE; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; GENETIC TRANSFECTION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTECTION; T LYMPHOCYTE; TUMOR CELL LINE; TUMOR IMMUNITY;

EID: 8544279650     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2004.06.002     Document Type: Article

References (33)

1. Bullock, T.N., Eisenlohr, L.C., 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184, 1319-1329.
2. Chen, W., Bennink, J.R., Yewdell, J.W., 2003. Systematic search fails to detect immunogenic MHC class-I-restricted determinants encoded by influenza A virus noncoding sequences. Virology 305, 50-54.
3. Elliott, T., Bodmer, H., Townsend, A., 1996. Recognition of out-of-frame major histocompatibility complex class I-restricted epitopes in vivo. Eur. J. Immunol. 26, 1175-1179.
4. Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., Rammensee, H.G., 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296.
5. Farabaugh, P.J., 1996. Programmed translational frameshifting. Annu. Rev. Genet. 30, 507-528.
6. Galy, B., Maret, A., Prats, A.C., Prats, H., 1999. Cell transformation results in loss of the density-dependent translational regulation of expression of fibroblast growth factor 2 isoforms. Cancer Res. 59, 165-171.
7. Harrington, L., Robinson, M.O., 2002. Telomere dysfunction: multiple paths to the same end. Oncogene 21, 592-597.
8. Huseby, E.S., Crawford, F., White, J., Kappler, J., Marrack, P., 2003. Negative selection imparts peptide specificity to the mature T cell repertoire. Proc. Natl. Acad. Sci. USA 100, 11565-11570.
9. Karttunen, J., Shastri, N., 1991. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc. Natl. Acad. Sci. USA 88, 3972-3976.
10. Laus, R., Graddis, T.J., Hakim, L, Vidovic, D., 2000. Enhanced major histocompatibility complex class I-dependent presentation of antigens modified with cationic and fusogenic peptides. Nat. Biotechnol. 18, 1269-1272.
11. Malarkannan, S., Horng, T., Shih, P.P., Schwab, S., Shastri, N., 1999. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity 10, 681-690.
12. + T cells. Cancer Res. 63, 6506-6515.
13. Mayrand, S.M., Green, W.R., 1998. Non-traditionally derived CTL epitopes: exceptions that prove the rules? Immunol. Today 19, 551-556.
14. + T cell clone on melanoma. J. Exp. Med. 191, 1617-1623.
15. Nanbru, C., Lafon, I., Audigier, S., Gensac, M.C., Vagner, S., Huez, G., Prats, A.C., 1997. Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J. Biol. Chem. 272, 32061-32066.
16. Naski, M.C., Wang, Q., Xu, J., Ornitz, D.M., 1996. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13, 233-237.
17. + tumor infiltrating lymphocyte. Cancer Res. 59, 6230-6238.
18. Peabody, D.S., 1987. Translation initiation at an ACG triplet in mammalian cells. J. Biol. Chem. 262, 11847-11851.
19. Probst-Kepper, M., Stroobant, V., Kridel, R., Gaugler, B., Landry, C., Brasseur, F., Cosyns, J.P., Weynand, B., Boon, T., Van Den Eynde, B.J., 2001. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8T lymphocytes. J. Exp. Med. 193, 1189-1198.
20. Rom, E., Kahana, C., 1994. Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame shifting. Proc. Natl. Acad. Sci. USA 91, 3959-3963.
21. Ronsin, C., Chung-Scott, V., Poullion, L, Aknouche, N., Gaudin, C., Triebel, F., 1999. A non-AUG-defined alternative open reading frame of the intestinal carboxy esterase mRNA generates an epitope recognized by renal cell carcinoma-reactive tumor-infiltrating lymphocytes in situ. J. Immunol. 163, 483-490.
22. Rosenberg, S.A., Tong-On, P., Li, Y., Riley, J.P., El-Gamil, M., Parkhurst, M.R., Robbins, P.F., 2002. Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy. J. Immunol. 168, 2402-2407.
23. Rudensky, A.Y., Preston-Hurlburt, P., Hong, S.C., Barlow, A., Janeway Jr, C.A., 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353, 622-627.
24. Sanderson, S., Shastri, N., 1994. LacZ inducible, antigen/MHC-specific T cell hybrids. Int. Immunol. 6, 369-376.
25. Shastri, N., Nguyen, V., Gonzalez, F., 1995. Major histocompatibility class I molecules can present cryptic translation products to T-cells. J. Biol. Chem. 270, 1088-1091.
26. Shastri, N., Schwab, S., Serwold, T., 2002. Producing nature's gene chips: the generation of peptides for display by MHC class I molecules. Annu. Rev. Immunol. 20, 463-493.
27. Small, E.J., Fratesi, P., Reese, D.M., Strang, G., Laus, R., Peshwa, M.V., Valone, F.H., 2000. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. J. Clin. Oncol. 18, 3894-3903.
28. Vagner, S., Touriol, C., Galy, B., Audigier, S., Gensac, M.C., Amalric, F., Bayard, F., Prats, H., Prats, A.C., 1996. Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells. J. Cell. Biol. 135, 1391-1402.
29. Vidovic, D., Matzinger, P., 1988. Unresponsiveness to a foreign antigen can be caused by self-tolerance. Nature 336, 222-225.
30. Vidovic, D., Graddis, T.J., Chen, F., Slagle, P., Diegel, M., Stepan, L., Laus, R., 2002. Antitumor vaccination with HER-2 derived recombinant antigens. Int. J. Cancer 102, 660-664.
31. Vidovic, D., Graddis, T.J., Stepan, L.P., Zaller, D.M., Laus, R., 2003. Specific stimulation of MHC-transgenic mouse T cell hybridomas with xenogeneic APC. Scand. J. Immunol. 64, 238-244.
32. Wang, R.F., Parkhurst, M.R., Kawakami, Y., Robbins, P.F., Rosenberg, S.A., 1996. Utilization of an alternative open reading frame of a normal gene in generating a human cancer antigen. J. Exp. Med. 183, 1131-1140.
33. + T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design. Cancer Res. 62, 3630-3635.